[1]
2025. Thymoquinone and chemoresistance in non-small cell lung cancer: Preclinical promise or therapeutic potential?. Journal of Current Biomedical Reports. 6, 1 (Mar. 2025), 27–28. DOI:https://doi.org/10.61882/jcbior.6.1.285.